Efficacy of Gaultheria procumbens 12C in reducing the triglyceride level in hypertriglyceridemia

EFFICACY OF GAULTHERIA PROCUMBENS 12C IN HYPERTRIGLYCERIDEMIA: A DOUBLE â?? BLIND PLACEBO CONTROLLED STUDY

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046608

Enrollment

Registered

2022-10-18

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

Intervention1: Homoeopathic medicines: A randomized controlled trial randomized to see the effectiveness into two groups by using block randomization procedure either group A (Gaultheria procumbens 1

Eligibility

Inclusion criteria

Inclusion criteria: Patient from 20-65 years of age irrespective of the gender. Patient with triglycerides level in between 150-500 mg/dl Patient who are not under conventional treatment for hypercholesteremia.

Exclusion criteria

Exclusion criteria: Evidence of trigylceridemia associated with pancreatitis. Patient with any complicated systemic illness. Immunocompromised patients. Pregnant and lactating mothers.

Design outcomes

Primary

Measure	Time frame
To determine the change in reducing the level of triglycerides in hypertriglyceridemia after administration of Gaultheria procumbens 12C.Timepoint: 6 months enrollment and 6 months follow up	—

Secondary

Measure	Time frame
To find out the changes in the lipid profile after Gaultheria procumbens. ii) To find out the changes in the values of liver function test after Gaultheria procumbens.Timepoint: 6 months enrollment and 6 months follow up	—

Countries

India

Contacts

Public ContactDR R S KRISHNESWARI

National homoeopathic Research Institute in Mental Health

krishneswarirs@gmail.com890325583

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026